Atria records impairment losses for Russian goodwill and lowers the Group's forecast for the remainder of the year. As a result of the goodwill impairment testing in Russia, the company's Board of Directors has decided that Atria Russia will record impairments totalling EUR 10.4 million allocated to goodwill. The impairments will have no effects on the cash flow, and they will be recorded in the performance of Q3/2010 as a non-recurrent item. The prices of meat raw materials in Russia have risen significantly during the period August-September. The price rises are expected to continue strong for the remainder of the year, which further weakens Atria Russia's prospects of results. The aim is to transfer the rise of raw material prices to the prices of end products, which may have a negative impact on the Q4/2010 net sales development. Because of Atria Russia's impairment losses and weakened prospects of results, the Group's EBIT for 2010 is estimated to be lower than that for 2009. Atria Group's net sales are also expected to remain somewhat below last year's level. Previously, Atria had estimated the Group's EBIT and net sales in 2010 to remain at the 2009 level. Atria will publish its Q3/2010 financial report on 27 October 2010. For further information, please contact Matti Tikkakoski, President and CEO, tel. +358 50 2582. ATRIA PLC Matti Tikkakoski President and CEO DISTRIBUTION Nasdaq OMX Helsinki Ltd Principal media www.atriagroup.com
Stock exchange releases | 15.10.2010